Prostate-specific antigen kallikrein is not a marker of non-ST elevation acute coronary syndrome

International Journal of Cardiology

Volumn 149, Issue 1, 2011, Pages 141-142

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Avanzas, Pablo ^c   Hernandez Garcia, Celestino ^a   Tome, Maria Carrillo Perez ^a   Lara Padron, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Acute coronary syndrome; Biomarker; Prostate specific antigen

Indexed keywords

GLUCOSE; KALLIKREIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION;

EID: 79955931111     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.02.010     Document Type: Article

References (13)

1. Patanè S, Marte F. Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going? Int J Cardiol 2011;146(1):e20-2.
2. Patanè S, Marte F. Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system. Eur Heart J 2009;30:1169-70.
3. Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 2003;108:250-2.
4. Hara M, Koyanagi Y, Inoue T, Fukuyama T. Some physico-chemical characteristics of "-seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII. Nihon Hoigaku Zasshi 1971;25:322-4.
5. Nash AF, Melezinek I. The role of prostate specific antigen measurement in the detection and management of prostate cancer. Endocr Relat Cancer 2000;7:37-51. (Pubitemid 30305870)
6. Graves HC. Nonprostatic sources of prostate-specific antigen: a steroid hormonedependent phenomenon? Clin Chem 1995;41:7-9.
7. Patanè S, Marte F. Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2010;138:e44-6.
8. Patanè S, Marte F, Di Bella G, Ciccarello G. Changing axis deviation and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2009;135:e4-5.
9. Patanè S, Marte F, Di Bella G, Ciccarello G. Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2009;137:e37-40.
10. Patanè S, Marte F. Paroxysmal atrial fibrillation during acute myocardial infarction associated with subclinical hyperthyroidism, severe three vessels coronary artery disease and elevation of prostate-specific antigen after TURP. Int J Cardiol 2010;138:e28-30.
11. Patanè S, Marte F, Sturiale M, Grassi R, Patanè F. Significant coronary artery disease associated with coronary artery aneurysm and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2010;141:e39-42.
12. Crook M, Preston K, Lancaster I. Serum prostatic specific-antigen concentrations in acute myocardial infarction. Clin Chem 1997;43:1670.
13. Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.